Insulet
PODD
#1056
Rank
A$28.19 B
Marketcap
$401.97
Share price
0.35%
Change (1 day)
40.75%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.61

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.63. In 2022 the company made an earnings per share (EPS) of $0.11 a decrease over its 2021 EPS that were of $0.35.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.612342.53%
2022$0.11-69.57%
2021$0.35109.09%
2020$0.17-38.89%
2019$0.28200%
2018$0.09173-113.04%
2017-$0.70-9.8%
2016-$0.78-60.77%
2015-$1.9939.78%
2014-$1.4212.05%
2013-$1.27-23.15%
2012-$1.6510.2%
2011-$1.50-36.36%
2010-$2.35-36.63%
2009-$3.72-29.36%
2008-$5.26-86.74%
2007-$39.67-64.04%
2006-$110.30122.23%
2005-$49.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.09-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.94-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.50-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.53 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.54 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.16 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$8.30 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA